Vaccines

08 Jul 2010 Crucell Reaches Agreement with Sanofi Pasteur on Programs in the Field of Paediatric and Respiratory Vaccines
08 Jul 2010 PharmAthene Develops Thermostable Lyophilized rPA Anthrax Vaccine Under a Challenge Grant From the National Institutes of Health
07 Jul 2010 Dynavax Initiates First Human Trial in Universal Flu Vaccine Program
06 Jul 2010 DBV Technologies Receives IND Clearance from FDA to Begin Clinical Trial in Peanut Allergy
02 Jul 2010 Intercell reports Phase II Study Results of its Vaccine Enhancement Patch for Pandemic Influenza
29 Jun 2010 Scancell Enters Research Collaboration with immatics to Develop Novel ImmunoBody Vaccines for Colorectal Cancer
29 Jun 2010 Immunovaccine Signs Agreement With Oncothyreon To Develop Cancer Vaccine
29 Jun 2010 Inovio Pharmaceuticals' Novel Gene Immunoadjuvant Significantly Improves DNA Vaccine Immune Responses in Non-Human Primates
28 Jun 2010 Mymetics' Respiratory Syncytial Virus (RSV) Vaccine Protects From Viral Challenge in Pre-Clinical Study
28 Jun 2010 STALLERGENES: Persistent Efficacy Demonstrated After a Year on Actair(R) Followed by a Second Treatment-Free Year
25 Jun 2010 Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax Administration
24 Jun 2010 Radient Phamacueticals Strategic Partner Jaiva Technologies Plans to Submit Application for Phase II Human Clinical Trials for Non-Small Cell Lung Carcinoma; Advancing Commercialization of RPC's CIT(TM) Cancer Vaccine in India
24 Jun 2010 Crucell Announces Start of Universal RSV Vaccine Program
23 Jun 2010 ImmunoCellular Therapeutics Announces Licensing Agreement with Targepeutics for Worldwide Intellectual Property Rights to Validated Immunotherapy Targ
22 Jun 2010 Ortho-McNeil-Janssen Pharmaceuticals, Inc. Enters Agreement to Develop and Commercialize Antigen-Based Therapy for Type 1 Diabetes
22 Jun 2010 Inovio Pharmaceuticals' Optimized DNA Vaccine Demonstrates Significant Advantages in Non-Human Primates Compared to Leading Viral Vector Based Vaccine
21 Jun 2010 Stallergenes: Staloral(R) Mites 300 Clinical Study in China: Efficacy is Demonstrated
17 Jun 2010 Mymetics' Phase Ib Malaria Vaccine: Safe, Well Tolerated and Long-Lasting Antibody Response in Children in Tanzania
17 Jun 2010 Merck KGaA Resumes Stimuvax Clinical Program in Lung Cancer
16 Jun 2010 IRX Therapeutics Raises $8 Million to Develop Therapeutic Vaccines for Cancer and Viral Diseases
16 Jun 2010 Vical's Allovectin-7(R) Phase 3 Trial Receives Positive Review From Safety Monitoring Board
15 Jun 2010 Inovio Pharmaceuticals Immunizes First Subject in U.S. Influenza DNA Vaccine Clinical Trial
15 Jun 2010 SCIB1 Immunobody DNA Vaccine Phase I Trial Commences
10 Jun 2010 tellar Biotechnologies Beginning Preclinical Testing
08 Jun 2010 Argos Therapeutics Presents Positive Phase 2 Data for Arcelis Dendritic Cell-based Immunotherapy in Advanced RCC at ASCO

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top